AU2002311701B2 - Kinetic assay - Google Patents

Kinetic assay Download PDF

Info

Publication number
AU2002311701B2
AU2002311701B2 AU2002311701A AU2002311701A AU2002311701B2 AU 2002311701 B2 AU2002311701 B2 AU 2002311701B2 AU 2002311701 A AU2002311701 A AU 2002311701A AU 2002311701 A AU2002311701 A AU 2002311701A AU 2002311701 B2 AU2002311701 B2 AU 2002311701B2
Authority
AU
Australia
Prior art keywords
hapten
linker
conjugate
ligand
large group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002311701A
Other languages
English (en)
Other versions
AU2002311701A1 (en
Inventor
Christian John Cook
John Stanton Mitchell
Yinqiu Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New Zealand Institute for Bioeconomy Science Ltd
Original Assignee
New Zealand Institute for Plant and Food Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Zealand Institute for Plant and Food Research Ltd filed Critical New Zealand Institute for Plant and Food Research Ltd
Publication of AU2002311701A1 publication Critical patent/AU2002311701A1/en
Application granted granted Critical
Publication of AU2002311701B2 publication Critical patent/AU2002311701B2/en
Assigned to THE NEW ZEALAND INSTITUTE OF PLANT AND FOOD RESEARCH LIMITED reassignment THE NEW ZEALAND INSTITUTE OF PLANT AND FOOD RESEARCH LIMITED Alteration of Name(s) in Register under S187 Assignors: THE HORTICULTURE AND FOOD RESEARCH INSTITUTE OF NEW ZEALAND LIMITED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
AU2002311701A 2001-05-14 2002-05-14 Kinetic assay Ceased AU2002311701B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ511705 2001-05-14
NZ511705A NZ511705A (en) 2001-05-14 2001-05-14 Methods and rapid immunoassay device for detecting progesterone and other steroids
PCT/NZ2002/000092 WO2002092631A1 (en) 2001-05-14 2002-05-14 Kinetic assay

Publications (2)

Publication Number Publication Date
AU2002311701A1 AU2002311701A1 (en) 2003-05-01
AU2002311701B2 true AU2002311701B2 (en) 2008-10-09

Family

ID=19928478

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002311701A Ceased AU2002311701B2 (en) 2001-05-14 2002-05-14 Kinetic assay

Country Status (7)

Country Link
US (1) US20040171069A1 (enExample)
EP (1) EP1404717A4 (enExample)
JP (1) JP2004538447A (enExample)
AU (1) AU2002311701B2 (enExample)
CA (1) CA2447032A1 (enExample)
NZ (1) NZ511705A (enExample)
WO (1) WO2002092631A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513880A1 (en) * 2003-01-21 2004-08-05 Micronics Inc. Method and system for microfluidic manipulation, amplification and analysis of fluids, for example, bacteria assays and antiglobulin testing
NZ528323A (en) * 2003-09-18 2006-05-26 Horticulture & Food Res Inst Immunoassay
GB0523366D0 (en) * 2005-11-16 2005-12-28 Univ Cardiff Method
DK2078197T3 (en) * 2006-11-01 2016-05-23 Ventana Med Syst Inc Haptenes, hapten conjugates, compositions thereof and processes for their preparation and use
WO2008106149A1 (en) * 2007-02-28 2008-09-04 Children's Medical Center Corporation Methods for predicting the onset of menarche
JP5416263B2 (ja) * 2011-09-26 2014-02-12 富士フイルム株式会社 蛍光粒子を用いたコルチゾール免疫アッセイ
US20150072438A1 (en) * 2012-04-18 2015-03-12 Siemens Healthcare Diagnostic Inc. Compounds and methods for preparation of conjugate reagents
CN103399696B (zh) * 2013-08-16 2018-10-09 上海合合信息科技发展有限公司 直线/线段吸附的方法及装置，构造多边形的方法及装置
US10690665B2 (en) 2014-07-01 2020-06-23 Nippon Steel Chemical & Materials Co., Ltd. Marker, immunoassay method, immunoassay reagent, method for assaying analyte, analyte measurement kit, and lateral-flow chromatographic test strip
CN105628924A (zh) * 2015-12-31 2016-06-01 苏州科铭生物技术有限公司 一种皮质酮含量测定试剂盒及其方法
CN111175499A (zh) * 2020-02-28 2020-05-19 江南大学 一种用于检测睾酮素的elisa试剂盒的制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880823A (en) * 1966-09-16 1975-04-29 Toyo Jozo Kk Process for preparing peptides using N-hydroxy succinimide mono-and dichloroacetate esters
US4039385A (en) * 1972-05-08 1977-08-02 Syva Company Cardiac glycoside enzyme conjugates
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4351760A (en) * 1979-09-07 1982-09-28 Syva Company Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
DE3224788A1 (de) * 1981-07-17 1983-02-03 South African Inventions Development Corp., Scientia, Pretoria,Transvaal Traegergebundenes immunogenes material
DE3263249D1 (en) * 1981-08-21 1985-05-30 Hoffmann La Roche Method for the determination of carcinoembryonic antigen (cea) and suitable antibody solution for the determination
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
JPS58194900A (ja) * 1982-05-10 1983-11-12 Shionogi & Co Ltd ４−または６−置換アルドステロン類，その製法およびそのイムノアツセイにおける使用法
US4687808A (en) * 1982-08-12 1987-08-18 Biospecific Technologies, Inc. Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors
EP0197521B1 (en) * 1985-04-09 1989-08-02 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Immunoglobulin adsorbent and adsorption apparatus
US4894348A (en) * 1987-07-01 1990-01-16 Ronald Robert C Fluorescein-conjugated proteins with enhanced fluorescence
US5196351A (en) * 1987-09-30 1993-03-23 Beckman Instruments, Inc. Bidentate conjugate and method of use thereof
DE3851682T2 (de) * 1987-10-30 1995-05-04 American Cyanamid Co Targetformer von Antitumor-Methyltrithioagenzien.
US5776713A (en) * 1988-02-02 1998-07-07 Biocode Ltd. Marking of products to establish identity and source
CA2049028A1 (en) * 1989-03-07 1990-09-08 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
CA2016584C (en) * 1989-05-17 1999-06-29 Robert S. Greenfield Anthracycline conjugates having a novel linker and methods for their production
DE3919915A1 (de) * 1989-06-19 1990-12-20 Boehringer Mannheim Gmbh Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen
WO1991014696A1 (en) * 1990-03-29 1991-10-03 Gilead Sciences, Inc. Oligonucleotide-transport agent disulfide conjugates
US5191066A (en) * 1990-12-07 1993-03-02 Abbott Laboratories Site-specific conjugation of immunoglobulins and detectable labels
DE4107570A1 (de) * 1991-03-07 1992-11-19 Diagnostikforschung Inst Chelate, deren metallkomplexe sowie ihre verwendung in diagnostik und therapie
CA2062240A1 (en) * 1991-06-07 1992-12-08 Susan J. Danielson Labeled hydantoin derivatives for immunoassays
US5578457A (en) * 1992-08-07 1996-11-26 Johnson & Johnson Clinical Diagnostics, Inc. Immunoassays with novel labeled carbamazepine hapten analogues
DE4311021A1 (de) * 1993-03-31 1994-10-27 Diagnostikforschung Inst Bifunktionelle Chelatbildner, deren Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende radiopharmazeutische Mittel
FR2706618B1 (fr) * 1993-06-11 1995-09-01 Bio Merieux Dispositif pour le dosage d'haptènes et son utilisation.
FR2707010B1 (enExample) * 1993-06-25 1995-09-29 Bio Merieux
US5773001A (en) * 1994-06-03 1998-06-30 American Cyanamid Company Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
DE4444002A1 (de) * 1994-12-10 1996-06-13 Behringwerke Ag Immunoassays für Haptene und hierfür verwendbare Haptentracer-Antikörper-Komplexe sowie Verfahren zur Herstellung derselben
US5620890A (en) * 1995-03-14 1997-04-15 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to hygromycin B and the method of making the same
US5876727A (en) * 1995-03-31 1999-03-02 Immulogic Pharmaceutical Corporation Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
AU7468196A (en) * 1995-10-27 1997-05-15 Merck & Co., Inc. Conjugates of gonadotropin releasing hormone
US5843682A (en) * 1995-11-20 1998-12-01 Boehringer Mannheim Corporation N-1-carboxyalkyl derivatives of LSD
DK0871490T3 (da) * 1995-12-22 2003-07-07 Bristol Myers Squibb Co Forgrenede hydrazonlinkere
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6339069B1 (en) * 1996-10-15 2002-01-15 Elan Pharmaceuticalstechnologies, Inc. Peptide-lipid conjugates, liposomes and lipsomal drug delivery
US5858653A (en) * 1997-09-30 1999-01-12 Surmodics, Inc. Reagent and method for attaching target molecules to a surface
DE19814814C2 (de) * 1998-04-02 2002-01-31 Gerhard Steffan Wasserlösliche, Iminophenazinderivate enthaltende pharmazeutische Zusammensetzungen, deren Herstellung und Verwendung
US6251382B1 (en) * 1998-04-17 2001-06-26 Enzon, Inc. Biodegradable high molecular weight polymeric linkers and their conjugates
JP2002513795A (ja) * 1998-05-04 2002-05-14 ヨハネス ケーゼル アンドレアス モノマー、オリゴマーおよびポリマーのクネベナーゲル縮合生成物
US6262264B1 (en) * 1998-06-01 2001-07-17 Roche Diagnostics Corporation Redox reversible imidazole osmium complex conjugates
US6703381B1 (en) * 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
CA2283597C (en) * 1998-10-02 2008-02-05 Ortho-Clinical Diagnostics, Inc. Reduced cortisol conjugates
PT1144609E (pt) * 1999-08-27 2008-05-28 Novartis Vaccines & Diagnostic Oligonucleótidos anti-sentido quiméricos e suas formulações para transfecção de células
US7169940B1 (en) * 1999-11-02 2007-01-30 Nst Neurosurvival Technologies Ltd. Compounds and pharmaceutical compositions comprising same
US6372907B1 (en) * 1999-11-03 2002-04-16 Apptera Corporation Water-soluble rhodamine dye peptide conjugates

Also Published As

Publication number Publication date
EP1404717A1 (en) 2004-04-07
WO2002092631A1 (en) 2002-11-21
CA2447032A1 (en) 2002-11-21
NZ511705A (en) 2004-03-26
US20040171069A1 (en) 2004-09-02
EP1404717A4 (en) 2006-03-08
JP2004538447A (ja) 2004-12-24

Similar Documents

Publication Publication Date Title
US4434236A (en) Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
US5028535A (en) Threshold ligand-receptor assay
US5296347A (en) Bridge immunoassay
US5939272A (en) Non-competitive threshold ligand-receptor assays
CA1255216A (en) Immunoassay for the detection of ligands
US5332679A (en) Method for specific binding assays using a releasable ligand
JP3340434B2 (ja) ジビニルスルホンに由来する成分を含んで成る水溶性ポリマーベース試薬及び抱合体
US5629164A (en) Enzyme immunoassay device
JPH07260784A (ja) 四級アンモニウム免疫原接合体およびイムノアッセイ試薬
JPS5994069A (ja) 分析対象物−シトリシン抱合体を用いる特殊結合分析
WO1995032428A1 (en) Reagents and methods for the rapid and quantitative assay of pharmacological agents
AU2002311701B2 (en) Kinetic assay
EP1390729A2 (en) Systems and methods for detection of analytes in biological fluids
JPH0760158B2 (ja) 分析物検出のための方法、試薬及び試験ストリップ
JPH02213766A (ja) 免疫測定用試薬および免疫測定器具
AU2002311701A1 (en) Kinetic assay
US5723304A (en) Immunological detection using two detectable labels
US5210040A (en) Process for coupling antibodies or antibody fragments to liposomes
US6225043B1 (en) Separation and analysis
JPH063449B2 (ja) 不均質免疫学的測定試験に用いるための安定な固定化ハプテン試薬及びその製造方法並びに用途
US20200209230A1 (en) Methods and compositions relating to small molecule analyte assays
US4971916A (en) Liposome based homogeneous immunoassay for diagnostic tests
JP2672151B2 (ja) 磁性体を利用した酵素免疫測定法
CA1309344C (en) Liposome based homogeneous immunoassay for diagnostic tests
EP0653065B1 (en) Separation method

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired